Stockholders' Equity (Tables)

6 Months Ended

Sep. 30, 2022

Stockholders Equity Note [Abstract]

Schedule of Stock-Based Compensation Expense

The following table summarizes total share-based compensation expense included in the condensed consolidated statements of net income (loss) and comprehensive income (loss) for the three and six months ended September 30, 2022 and 2021:

	Three Months Ended September 30,						Six Months Ended September 30,
	2022			2021			2022			2021
Costs and expenses:
Cost of revenue	$	951		$	554		$	1,514		$	1,058
Research and development costs		1,655			1,110			3,238			2,153
Selling, general and administrative		6,081			3,559			12,701			8,424
Total share-based compensation		8,687			5,223			17,453			11,635
Income tax benefit		(2,078	)		(1,151	)		(4,123	)		(2,733	)
Decrease in net income	$	6,609		$	4,072		$	13,330		$	8,902

Summary of Stock Option Activity

The following table summarizes the stock option transactions during the six months ended September 30, 2022:

				Weighted-		Weighted-
				Average		Average		Aggregate
				Exercise		Remaining		Intrinsic
	Number of			Price		Contractual		Value
	Shares			per Share		Life (years)		(in thousands)
Outstanding, March 31, 2022		1,453,739		$	14.80		2.9	$	8,886
Exercised		(85,026	)		14.64		1.8		440
Expired		(2,000	)		15.99
Outstanding, September 30, 2022		1,366,713		$	14.81		2.4	$	4,020
Vested and expected to vest, September 30, 2022		1,365,730		$	14.81		2.4	$	4,017
Exercisable, September 30, 2022		1,360,463		$	14.81		2.4	$	4,003

Schedule of Employee Stock Options and Performance Based Awards by Non-vested Stock Options

Non-vested stock option award activity during the six months ended September 30, 2022 is summarized as follows:

				Weighted-
				Average
				Grant-Date
	Number of			Fair Value
	Shares			per Share
Outstanding, March 31, 2022		50,382		$	6.98
Vested		(44,132	)		7.12
Outstanding, September 30, 2022		6,250		$	5.96

Summary of Restricted Stock Awards Activity

Restricted stock awards activity during the six months ended September 30, 2022 is summarized as follows:

				Weighted-
				Average
				Grant-Date
	Number of			Fair Value
	Shares			per Share
Outstanding, March 31, 2022		3,242,763		$	15.30
Granted		1,361,471			17.79
Vested		(1,024,872	)		15.17
Canceled		(141,485	)		16.50
Outstanding, September 30, 2022		3,437,877		$	16.27